Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics | RCV000517022 | SCV000613493 | uncertain significance | not specified | 2017-06-26 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV005091183 | SCV005840458 | uncertain significance | Charcot-Marie-Tooth Neuropathy X | 2024-11-18 | criteria provided, single submitter | clinical testing | This sequence change replaces valine, which is neutral and non-polar, with phenylalanine, which is neutral and non-polar, at codon 192 of the GJB1 protein (p.Val192Phe). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This missense change has been observed in individual(s) with Charcot-Marie-Tooth disease (PMID: 9818870, 22464564). ClinVar contains an entry for this variant (Variation ID: 447437). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed for this missense variant. However, the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on GJB1 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Inherited Neuropathy Consortium | RCV000789285 | SCV000928638 | uncertain significance | Charcot-Marie-Tooth disease | no assertion criteria provided | literature only |